| Ms Karolina Jevaltaite-harmon, LPC, LLMFT | |
|
7195 Thornapple River Dr Se, Ada, MI 49301-8411 | |
| (616) 929-0248 | |
| Not Available |
| Full Name | Ms Karolina Jevaltaite-harmon |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 7195 Thornapple River Dr Se, Ada, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003451667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 6401017761 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karolina Jevaltaite-harmon, LPC, LLMFT 7195 Thornapple River Dr Se, Ada, MI 49301-8411 Ph: () - | Ms Karolina Jevaltaite-harmon, LPC, LLMFT 7195 Thornapple River Dr Se, Ada, MI 49301-8411 Ph: (616) 929-0248 |
News Archive
Australian researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia.
A possible cause has been found for the disrupted communication between brain cells exhibited by Parkinson's patients. Bettina Schwab, a researcher at the University of Twente in The Netherlands, discovered that this group of patients have increased concentrations of a certain type of protein. Ms Schwab defended her doctoral dissertation on Friday 22 April.
Scientists at UCLA have discovered a new genetic risk factor for Alzheimer's disease by screening people's DNA and then using an advanced type of scan to visualize their brains' connections.
Stroke risk for patients with traumatic brain injuries is at its highest in the four months following injury and remains significant for up to five years post-injury, finds a new systematic review led by a team at the University of Birmingham.
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
› Verified 2 days ago
Mr. John Ostrowski Jr., MA, LPC/S, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7955 Thornapple Club Dr Se, Ada, MI 49301 Phone: 616-881-6262 | |
Shelby Negro, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7195 Thornapple River Dr Se Ste C, Ada, MI 49301 Phone: 586-854-6737 | |
Karen Feaster, Counselor Medicare: Not Enrolled in Medicare Practice Location: 455 Greentree Ln Ne, Ada, MI 49301 Phone: 616-340-2158 Fax: 269-686-5201 | |
Mrs. Maryam Jearbell Yahya, LLPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4764 Fulton St E Ste 204, Ada, MI 49301 Phone: 616-439-0007 | |
Robert B. Thompson, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8945 Vergennes St Se, Ada, MI 49301 Phone: 616-643-0869 | |
Molly Rose Wilson, PH.D., LLPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7195 Thornapple River Dr Se, Ada, MI 49301 Phone: 616-929-0248 |